Public Research Snapshot
GridAI Technologies Corp is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates.
GRDX Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway
GridAI Technologies Corp | Needs refresh | Last updated: 2026-06-01T17:55:29Z
TickerGRDX
Market Cap42.5M
Cash RunwayRunway < 6 months
Next Catalystn/a
Pipeline
| Asset | Indication | Modality | Stage | Public Note |
|---|---|---|---|---|
| No public pipeline rows are loaded yet. | ||||
Catalyst Preview
No public catalyst rows matched this view yet.
Cash Runway Preview
Estimated cash runway: Runway < 6 months.
This is an automated estimate and may differ from company guidance.
Recent SEC Filings
- No public filing rows are loaded yet.
Clinical Trial Activity
| NCT ID | Phase | Status | Enrollment | Primary Completion |
|---|---|---|---|---|
| No public trial rows are loaded yet. | ||||
Scientific Context
- literature_publication | MXene-based hybrid nanocomposites for enhanced enzyme-electrode electron transfer for high-performance glucose biosensing.
- literature_publication | Hardened-layer depth measurement without prior velocity knowledge: An experimental study using FMC phased-array ultrasonics and CMP gathers.
- literature_publication | Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women.
- literature_publication | What does infection cost? A comparative analysis of shoulder, hip, and knee two-stage revision procedures.
- literature_publication | Distinguishing Tracheobronchomalacia and Excessive Dynamic Airway Collapse on Dynamic CT Images.
Want the full GRDX research brief?
Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.
Get the weekly biotech catalyst watchlistThis page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.